These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9580755)
1. Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. Wilson DC; Ellis L; Zielenski J; Corey M; Ip WF; Tsui LC; Tullis E; Knowles MR; Durie PR J Pediatr; 1998 Apr; 132(4):596-9. PubMed ID: 9580755 [TBL] [Abstract][Full Text] [Related]
5. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis. Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854 [TBL] [Abstract][Full Text] [Related]
6. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis? Ooi CY; Dupuis A; Gonska T; Ellis L; Ni A; Jarvi K; Martin S; Ray P; Steele L; Kortan P; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P Ann Am Thorac Soc; 2014 May; 11(4):562-70. PubMed ID: 24697796 [TBL] [Abstract][Full Text] [Related]
7. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport. Sermet-Gaudelus I; Girodon E; Sands D; Stremmler N; Vavrova V; Deneuville E; Reix P; Bui S; Huet F; Lebourgeois M; Munck A; Iron A; Skalicka V; Bienvenu T; Roussel D; Lenoir G; Bellon G; Sarles J; Macek M; Roussey M; Fajac I; Edelman A Am J Respir Crit Care Med; 2010 Oct; 182(7):929-36. PubMed ID: 20538955 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. Wilschanski M; Dupuis A; Ellis L; Jarvi K; Zielenski J; Tullis E; Martin S; Corey M; Tsui LC; Durie P Am J Respir Crit Care Med; 2006 Oct; 174(7):787-94. PubMed ID: 16840743 [TBL] [Abstract][Full Text] [Related]
11. Nasal potential difference in congenital bilateral absence of the vas deferens. Pradal U; Castellani C; Delmarco A; Mastella G Am J Respir Crit Care Med; 1998 Sep; 158(3):896-901. PubMed ID: 9731023 [TBL] [Abstract][Full Text] [Related]
12. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype. Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294 [TBL] [Abstract][Full Text] [Related]
13. Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests. Augarten A; Shmilovich H; Doolman R; Aviram M; Akons H; Ben Tur L; Blau H; Kerem E; Rivlin J; Sela BA; Szeinberg A; Yahav Y Pediatr Pulmonol; 2000 Oct; 30(4):320-3. PubMed ID: 11015133 [TBL] [Abstract][Full Text] [Related]
14. Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis? Ooi CY; Dupuis A; Ellis L; Jarvi K; Martin S; Ray PN; Steele L; Kortan P; Gonska T; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P Thorax; 2014 Mar; 69(3):254-60. PubMed ID: 24149827 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis. Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346 [TBL] [Abstract][Full Text] [Related]
16. [Cystic fibrosis and normal sweat chloride values: a case-report]. Lebecque P; Leal T; Godding V Rev Mal Respir; 2001 Sep; 18(4 Pt 1):443-5. PubMed ID: 11547256 [TBL] [Abstract][Full Text] [Related]
17. Laboratory tests for the diagnosis of cystic fibrosis. Wang L; Freedman SD Am J Clin Pathol; 2002 Jun; 117 Suppl():S109-15. PubMed ID: 14569807 [TBL] [Abstract][Full Text] [Related]
18. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening. Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149 [TBL] [Abstract][Full Text] [Related]
19. Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C. Massie RJ; Poplawski N; Wilcken B; Goldblatt J; Byrnes C; Robertson C Eur Respir J; 2001 Jun; 17(6):1195-200. PubMed ID: 11491164 [TBL] [Abstract][Full Text] [Related]
20. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data. Derichs N; Sanz J; Von Kanel T; Stolpe C; Zapf A; Tümmler B; Gallati S; Ballmann M Thorax; 2010 Jul; 65(7):594-9. PubMed ID: 20627915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]